SCIMED ANNOUNCES NEW PRODUCT
SCIMED ANNOUNCES NEW PRODUCT MINNEAPOLIS, April 13 /PRNewswire/ -- SCIMED Life Systems, Inc.
(NADAQ-NMS: SMLS) announced today the introduction of the COBRA(TM) 10 coronary balloon angioplasty catheter. The COBRA 10 is an over-the-wire catheter compatible with .010" guide wires and enables SCIMED to compete in a new market segment estimated to be $25 million annually. The COBRA 10 is the smallest over-the-wire device currently available and provides the same important features of the COBRA 14 Q proximal COBRAID(TM) technology for superior push, distal high density Scilene(TM) along with patented taper technology for superior track, and the energy transfer segment which transfers proximal push into distal track.
SCIMED Life Systems, Inc. develops, manufactures, and markets disposable medical devices, principally coronary angioplasty catheters, for interventional treatment of coronary artery disease. SCIMED's shares are traded on the NASDAQ National Market System under the symbol SMLS. -0- 4/13/92 /Contact: Karen J. Kelsey of SCIMED Life Systems, 612-420-0329/ (SMLS) CO: SCIMED Life Systems, Inc. ST: Minnesota IN: MTC SU: PDT
AL -- MN009 -- 7660 04/13/92 10:37 EDT
|Printer friendly Cite/link Email Feedback|
|Date:||Apr 13, 1992|
|Previous Article:||NEW CREF GLOBAL EQUITIES ACCOUNT EXPANDS DIVERSIFICATION OF TIAA-CREF RETIREMENT SYSTEM|
|Next Article:||STERLING SOFTWARE REGISTERS WITH SEC TO OFFER 2 MILLION SHARES OF COMMON STOCK|